Old Web
English
Sign In
Acemap
>
authorDetail
>
P Selema
P Selema
Pfizer
Medicine
Biosimilar
Physical therapy
Interim analysis
Diabetes mellitus
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)
2021
Rheumatology Advances in Practice
P.C. Taylor
Robin Christensen
Shahrzad Moosavi
P Selema
R. Guilatco
Heather Fowler
M. Mueller
K. F. Liau
B. Haraoui
Show All
Source
Cite
Save
Citations (0)
P590 An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab
2019
Journal of Crohns & Colitis
B. Bokemeyer
Tibor Hlavatý
M. Allez
P Selema
S Moosavi
M J Cadatal
H Fowler
R Cheung
Milan Lukas
Javier P. Gisbert
Show All
Source
Cite
Save
Citations (0)
1